Palatin Announces Positive Preclinical Data for Oral MC4R Agonist PL7737 in Obesity

Palatin Technologies announced positive preclinical results for PL7737, an oral MC4R agonist, demonstrating significant weight loss in obese rodent mo...
Home/KnloSights/Clinical Trial Updates/Palatin Announces Positive Preclinical Data for Oral MC4R Agonist PL7737 in Obesity